395 related articles for article (PubMed ID: 11774085)
1. Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program.
Phillips P; Chan K; Hogg R; Bessuille E; Black W; Talbot J; O'Shaughnessy M; Montaner J
Clin Infect Dis; 2002 Feb; 34(3):371-8. PubMed ID: 11774085
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium avium complex infection in HIV/AIDS patients.
Corti M; Palmero D
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):351-63. PubMed ID: 18588499
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.
Zeller V; Truffot C; Agher R; Bossi P; Tubiana R; Caumes E; Jouan M; Bricaire F; Katlama C
Clin Infect Dis; 2002 Mar; 34(5):662-7. PubMed ID: 11810599
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002.
Brooks JT; Song R; Hanson DL; Wolfe M; Swerdlow DL;
Clin Infect Dis; 2005 Aug; 41(4):549-53. PubMed ID: 16028167
[TBL] [Abstract][Full Text] [Related]
6. MAC prophylaxis in the era of polypharmacy.
Sawhney N
WMJ; 1999; 98(3):46-8. PubMed ID: 10414219
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
Karakousis PC; Moore RD; Chaisson RE
Lancet Infect Dis; 2004 Sep; 4(9):557-65. PubMed ID: 15336223
[TBL] [Abstract][Full Text] [Related]
8. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team.
Aberg JA; Williams PL; Liu T; Lederman HM; Hafner R; Torriani FJ; Lennox JL; Dube MP; MacGregor RR; Currier JS;
J Infect Dis; 2003 Apr; 187(7):1046-52. PubMed ID: 12660918
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of azithromycin for preventing Mycobacterium avium complex infection in HIV-positive patients in the era of highly active antiretroviral therapy. The Swiss HIV Cohort Study.
Sendi PP; Craig BA; Meier G; Pfluger D; Gafni A; Opravil M; Battegay M; Bucher HC
J Antimicrob Chemother; 1999 Dec; 44(6):811-7. PubMed ID: 10590283
[TBL] [Abstract][Full Text] [Related]
10. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion.
Lederman HM; Williams PL; Wu JW; Evans TG; Cohn SE; McCutchan JA; Koletar SL; Hafner R; Connick E; Valentine FT; McElrath MJ; Roberts NJ; Currier JS;
J Infect Dis; 2003 Dec; 188(12):1794-803. PubMed ID: 14673757
[TBL] [Abstract][Full Text] [Related]
11. Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy.
Aberg JA; Chin-Hong PV; McCutchan A; Koletar SL; Currier JS
Clin Infect Dis; 2002 Jul; 35(1):E8-E13. PubMed ID: 12060894
[TBL] [Abstract][Full Text] [Related]
12. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
Lange CG; Woolley IJ; Brodt RH
Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
[TBL] [Abstract][Full Text] [Related]
13. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD
Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
[TBL] [Abstract][Full Text] [Related]
14. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
Wright J
Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
[TBL] [Abstract][Full Text] [Related]
15. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
Cohn DL
Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
[TBL] [Abstract][Full Text] [Related]
16. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
[TBL] [Abstract][Full Text] [Related]
18. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?
Yangco BG; Buchacz K; Baker R; Palella FJ; Armon C; Brooks JT;
AIDS Patient Care STDS; 2014 Jun; 28(6):280-3. PubMed ID: 24833016
[TBL] [Abstract][Full Text] [Related]
19. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
Phillips P; Bonner S; Gataric N; Bai T; Wilcox P; Hogg R; O'Shaughnessy M; Montaner J
Clin Infect Dis; 2005 Nov; 41(10):1483-97. PubMed ID: 16231262
[TBL] [Abstract][Full Text] [Related]
20. [Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment].
Schneider MM; Reiss P; Borleffs JC; Rozenberg-Arska M; Hoepelman IM
Ned Tijdschr Geneeskd; 1997 Jan; 141(2):80-3. PubMed ID: 9036351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
